Mayo Clinic to build £183m integrated oncology facility in Florida
June 27, 2019 – US-based non-profit academic medical centre Mayo Clinic announced that it will construct a $233m (£183.5m) integrated oncology facility at its Florida campus.
The new 140,000ft² integrated oncology facility will include a proton beam therapy and also deliver radiotherapy to cancer patients.
To be located near the Mangurian Building and the Oncology Infusion Center, the new oncology facility is expected to be completed in the later part of 2023.
The Mangurian Building houses haematology and oncology care. Mayo Clinic believes that keeping these services close by will best serve its cancer patients and can also help in further integrating cancer care at the Florida campus. The facility will include a two-gantry proton radiotherapy system.
The new facility is expected to be of significant importance in integrated cancer practice at Mayo Clinic, helping to serve cancer patients. The new facility with its proton beam therapy in the integrated oncology facility is claimed to make Mayo Clinic more competitive with other leading cancer centres.
Of the overall investment of $233m (£183.5m), $211m (£166m) will be spent for the integrated oncology facility support tower and advanced radiation equipment, including proton beam. The remaining $22m (£17m) will be invested in parking and patient walkways.
Mayo Clinic Florida CEO Kent Thielen said: “This facility will give us the ability to offer our patients the full spectrum of cancer treatment options, including chemotherapy, immunotherapy, CAR-T cell therapy (chimeric antigen receptor therapy T cell therapy), surgery, proton beam therapy, gamma knife radiosurgery and traditional radiotherapy.
“It will also give patients access to proton beam therapy clinical trials offered through our National Cancer Institute-designated comprehensive cancer center.”
Mayo Clinic said that its Proton Beam Therapy Program uses pencil beam scanning to deliver precise radiotherapy with lower doses of radiation to healthy tissue, which could reduce toxicity and negative side effects in patients. Such a targeted therapy is claimed to be a better option for people with tumours close to, or in vital organs.
Previously, Mayo Clinic introduced proton beam therapy at its campuses in Rochester, Minnesota, in 2015 and Phoenix in 2016.